AIIMS Expert Warns: Weight Loss Drugs Are Serious Medicines, Not Quick Fixes

An AIIMS expert has issued a strong warning against the reckless use of new generic weight loss drugs like semaglutide, emphasizing they are serious medicines for a serious problem. Dr Nikhil Tandon stresses that physical activity and diet are the foundational steps for weight loss, with medication being a last resort under medical supervision. The arrival of cheaper generic versions following patent expirations has increased accessibility, but also raised concerns about potential misuse. Doctors and regulators are urging strict pharmacovigilance and supervision, as the CDSCO has warned companies against promoting these prescription drugs to the general public.

Key Points: AIIMS Expert Warns Against Reckless Use of Weight Loss Drugs

  • Generic semaglutide enters Indian market
  • AIIMS expert warns of side effects
  • Lifestyle changes are primary solution
  • Drugs require strict doctor supervision
  • CDSCO issues advisory against public promotion
3 min read

'Weight loss drugs serious medicines for serious problem, shouldn't be used recklessly,' warns AIIMS expert

AIIMS expert Dr Nikhil Tandon cautions that generic weight loss drugs like semaglutide are serious medicines with side effects and should not be used recklessly.

"One should not consume it recklessly as these are serious medicines for a serious problem. - Dr Nikhil Tandon"

By Shalini Bhardwaj, New Delhi, March 23

The generic semaglutide has entered the Indian market at a huge discount compared to innovator products already available, according to an expert from AIIMS, Dr Nikhil Tandon, professor and HOD of the Department of Endocrinology and Metabolism.

Dr Nikhil Tandon told ANI, "One should not consume it (generic semaglutide) recklessly as these are serious medicines for a serious problem. People should be careful, as there can be side effects."

With the patent expirations for GLP-1 drugs, used for treating type 2 diabetes and obesity, major Pharma companies in India are lining up cheaper generic alternatives.

These alternatives are likely to be priced at a significantly lower price as compared to the current costs. According to the National Family Health Survey (NFHS-5, 2019-21), nearly 24 per cent of women and 23 per cent of men are overweight or obese, which has resulted in the increase in popularity of GLP-1 drugs.

Dr Tandon also said that physical activity and diet also plays important role in achieving weight loss, and if still not reducing the weight, then consult a doctor.

"We can take many steps to reduce obesity. The first and foremost step towards it is physical activities and diet. The medicines which are used in weight control are always given with a foundation of diet control and physical activity. We have to make changes in our lifestyle first to achieve weight loss. After all this, if we are still not achieving the required weight, we should consult a doctor. Earlier, there were some medicines for weight loss which were withdrawn due to their side effects. A medicine is only approved when the benefits outweigh the risks, and it can reduce up to 5 per cent of your weight," he said.

On GLP-1, he said, "The GLP-1 was initially used for diabetic management but was later found to have an impact on weight."

Earlier, Dr V Mohan, renowned diabetologist and Chairman of Dr Mohan's Diabetes Specialities Centre and Madras Diabetes Research Foundation, said, "Strict pharmacovigilance must be maintained."

He also said that these drugs are effective, but side effects can occur, so more Indian data needs to be collected.

"While they are very effective and fairly safe, side effects can occur, but more Indian data needs to be collected."

He further said that these drugs must be prescribed by qualified doctors. "This will make it accessible to many more people, and quality is important. People are advised to strictly use these drugs under the advice and supervision of a doctor, as these drugs can these drugs are very powerful and can produce side effects in some people," he said.

Recently, the Central Drugs Standard Control Organisation (CDSCO) issued a strict advisory warning pharmaceutical companies against promoting prescription weight drugs to the general public. Doctors say this diktat must be followed by all.

- ANI

Share this article:

Reader Comments

R
Rohit P
Finally, a voice of reason. Everyone wants a quick fix. Cheaper generics are good for accessibility, but if people start self-medicating, it will be a disaster. Our bodies react differently. We need the Indian data Dr. Mohan is talking about.
A
Aditya G
Good step by CDSCO. Pharma companies should not be allowed to advertise these directly to public like shampoo or biscuits. Obesity is a medical condition, not a cosmetic issue. Hope doctors also prescribe responsibly and not just for minor weight loss.
S
Sarah B
As someone who has struggled with weight, I understand the desperation. But the experts are right. I tried diet and exercise for 6 months with a nutritionist before my doctor even discussed medication. It's a tool, not a replacement for hard work. 💪
K
Karthik V
The price drop is a double-edged sword. It will help genuine patients who need it for diabetes or severe obesity. But it also makes it easier to misuse. Strict pharmacovigilance is the key word here.
N
Nikhil C
Respectfully, while the warning is needed, we also must acknowledge that for many, diet and exercise alone haven't worked despite years of trying. Medical science has advanced. These drugs, under supervision, can be a lifeline. Let's not stigmatize them either.
M

We welcome thoughtful discussions from our readers. Please keep comments respectful and on-topic.

Leave a Comment

Minimum 50 characters 0/50